A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
Status unconfirmed · Phase 2
Conditions studied: Prostatic Hyperplasia
In brief
Patients who are currently symptomatic and have been diagnosed with BPH by a physician may qualify for this 20-week study. Patients must not be diabetic, must not have prostate cancer and must not have had any surgery to repair your prostate or treat your BPH. Patients will first undergo a phone screening to confirm their eligibility and interest and to rule out any exclusionary history or medications. Eligible patients will be scheduled to come in to the clinic to sign an Informed Consent Form. Patients will then undergo blood and urine tests, a complete physical examination and history and answer several questionnaires to determine their eligibility. Patients will have a total of at least 7-8 visits over 20 weeks to the clinic during this study.Qualified patients receive free study medication, free medical care (physical examinations, EKG, laboratory tests) for the duration of the study.
Key facts
- Study ID
- NCT00044226
- Run by
- Milkhaus Laboratory
- People needed
- 350
- Starts
- 2002-04-01
- Expected to finish
- 2002-10-01
- Last updated by the study team
- 2005-06-24
Who can join
Age: 45 and older, up to 80. Sex: male. Healthy volunteers: accepted.
Where it is running
- Charles White, MD — Mobile, Alabama, United States (enrolling)
- Douglas Young, MD — Fair Oaks, California, United States (enrolling)
- Rodney Anderson, MD — Stanford, California, United States (enrolling)
- Eugene Dula, MD — Van Nuys, California, United States (enrolling)
- Joel Kaufman, MD — Aurora, Colorado, United States (enrolling)
- Donald Bergner, MD — Clearwater, Florida, United States (enrolling)
- Ira Klimberg, MD — Ocala, Florida, United States (enrolling)
- Gary Friedlander, MD — Rockville, Maryland, United States (enrolling)
- Sheldon Freedman, MD — Las Vegas, Nevada, United States (enrolling)
- Edward Loizides, MD — Bay Shore, New York, United States (enrolling)
- Richard Landau, MD — Sellersville, Pennsylvania, United States (enrolling)
- H. Pat Hezmall, MD — Fort Worth, Texas, United States (enrolling)
- Michael Godschalk, MD — Richmond, Virginia, United States (enrolling)
- Roger Fincher, MD — Spokane, Washington, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.